Cancer Bio-markers
<p style=""text-align:" justify;"="">A biomarker may be used to see how well the body responds to a treatment for a disease or condition. A use of biomarkers in cancer research is developing drug targets and Surrogate endpoints.While numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers have already been used at some point in patient care; including, Liver Cancer, Chronic Myeloid Leukemia BRCA1 / BRCA2 (Breast/Ovarian Cancer), Melanoma/Colorectal Cancer, Ovarian Cancer Pancreatic Cancer
Types of cancer biomarkers
- Breast
- Colorectal
- Leukemia/Lymphoma
- Gastric
- Lung
- Melanoma
- Pancreas
In cancer research, biomarkers are used in three primary ways
- To help diagnose conditions, as in the case of identifying early stage cancers (Diagnostic)
- To forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment.
- To predict how well a patient will respond to treatment.
Related Conference of Cancer Bio-markers
Cancer Bio-markers Conference Speakers
Recommended Sessions
- Advancements in Radiology
- Anti-Cancer Agents
- Cancer Bio-markers
- Cancer Immunotherapy & Vaccines
- Cancer Screening, Diagnosis & Prevention
- Cancer Treatment Research
- Case Reports
- Computed tomography
- Magnetic Resonance Imaging
- Mammography
- Novel Approaches to Cancer Therapeutics
- Pediatric Radiology
- Positron Emission Tomography
- Radiation oncology
- Radiation Therapy Accidents
- Radiology Imaging
- Stem Cell Transplant
- Tumour immunology & immunotherapy